RESMED INC — Director's Dealing 2021

Oct 13, 2021

SEC Form 4/A — Form 4/A

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-08-19

Reporting Person: Hollingshead James (President, Sleep Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-19	ResMed Common Stock	A	5741	—	Acquired	79279	Direct
2021-08-19	ResMed Common Stock	A	1332	—	Acquired	80611	Direct

Footnotes

F1: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on August 19, 2021, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.

F2: Represents performance-based restricted stock units granted on July 1, 2020 and reportable back on August 19, 2021. The shares were earned when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.